OSDrC® Data

In numerous tests comparing OSDrC® to the performance of conventional tableting machines and reproducibility of the tablets, OSDrC® technology has proven itself better than existing tablet technology.OSDrC® technology and equipment are protected by patents and the overall patent estate is continuously being expanded to fully protect the technology.

Low Cross-Contamination

The top, side, and bottom of the coating on tablets produced by an OSDrC® rotary tableting machine were each measured for cross-contamination with the core substance. These measurements demonstrated that the amount of API (acetaminophen) that migrated from the core to the coating was extremely low (less than 0.03%). OSDrC® technology is clearly effective at controlling the interaction of the API and the coating excipient.

Low Cross-Contamination
Yuichi Ozeki
"The Nakai Award winner's article" Development of one-step dry-coated tablets (OSDrC®) and the study for its physical characteristics,
Journal of Japan Society of Pharmaceutical Machinery and Engineering, Japan. vol 14/4 pp. 12-21 (2005)